International Psoriasis Council

Advancing Knowledge. Improving Care.

Masamoto

Murakami

,

MD, PhD

Director
M. Cubed
Ehime
,
Japan
Councilor Since: February 1, 2018
IPC Councilor
Dr. Masamoto Murakami is a Japanese dermatologist and pathologist with over three decades of experience in translational skin research, clinical dermatology, and cross-disciplinary medicine. He currently serves as the Director of M. Cubed, an independent medical science consultancy, and holds visiting professorships at Tokyo Medical University (Dermatology), Nagoya City University (Dermatology), Miyazaki University (Histochemistry and Cell Biology), and Kanagawa Dental University (Pathology).

Dr. Murakami earned his medical degree from St. Marianna University School of Medicine in 1990 and completed his PhD in Pathology at Fujita Health University in 1995. He subsequently held academic and clinical posts at institutions including Asahikawa Medical University and Ehime University, where he was appointed Professor of Dermatology in 2021. He also worked as a postdoctoral fellow in Dermatology at the University of California, San Diego. His research focuses on the pathomechanisms of chronic inflammatory skin diseases, particularly palmoplantar pustulosis (PPP), psoriasis, and acquired idiopathic generalized anhidrosis (AIGA). He is widely recognized for his pioneering work on antimicrobial peptides (especially LL-37), sweat gland biology, and the role of Th17 cell plasticity in pustular diseases. He is the first to report the loss and atrophy of eccrine glands in AIGA.

Dr. Murakami has led numerous clinical trials as principal investigator and contributed to over 150 peer-reviewed publications. His work has received support from the Japan Agency for Medical Research and Development (AMED), the Japan Society for the Promotion of Science Grants-in-Aid for Scientific Research (JSPS KAKENHI), and multiple pharmaceutical companies. In addition to his academic career, Dr. Murakami is the Director of the Non-profit Organization for Transdisciplinary Research on Diseases (NOTRD), which promotes collaboration across dermatology, immunology, pathology, and dentistry. He has also served on editorial boards and scientific committees of national and international societies.
Last Updated:
06/26/2025

Areas of Interest

Pustulosis, palmoplantar pustulosis, and psoriasis.

IPC Committees / Groups

Palmoplantar Pustulosis (PPP) Working Group

Languages Spoken

English, Japanese

Involvement with Other Organization(s)

Advisor to the Ehime district, Japan Psoriasis Association.

What's New

Use and Misuse of Systemic Corticosteroids in Psoriasis

In this Take Ten with IPC video, Professor Peter van de Kerkhof discusses the use and misuse of systemic corticosteroids in psoriasis. He questions whether they contraindicate the treatment of psoriasis, while also covering his personal experience in prescribing them.

WATCH NOW

Thursday, May 14, 2026

Use and Misuse of Topical Corticosteroids in Psoriasis

In this Take Ten with IPC video, Professor Peter van de Kerkhof discusses the use and misuse of topical corticosteroids in psoriasis, covering current use, guidelines, and consequences.

WATCH NOW

Thursday, May 14, 2026

Videos Now Available from the IEC & IPC Joint Symposium at AAD

Missed the joint symposium hosted by the International Eczema Council (IEC) and International Psoriasis Council (IPC) at the American Academy of Dermatology (AAD) Annual Meeting? Select presentations from Psoriasis or Dermatitis? When Boundaries Blur and Treatments Flip the Script are now available, covering diagnostic overlap, emerging tools, treatment-related reactions, and practical strategies for managing complex cases across diverse patient populations.

WATCH NOW

Wednesday, May 27, 2026